Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2026-01-29 @ 8:42 PM
Study NCT ID:
NCT03531918
Status:
COMPLETED
Last Update Posted:
2023-08-30
First Post:
2018-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Myeloid Leukemia | View |
Keywords: